We are live on
!
Find out more
Parallel Advisors Portfolio holdings
AUM
$6.56B
Turnover
11.49%
1-Year Est. Return
32.24%
This Fund
S&P 500
This Quarter
Est. Return
+8.88%
1 Year Est. Return
+32.24%
3 Year Est. Return
+108.68%
5 Year Est. Return
+114.41%
10 Year Est. Return
–
AUM
$5B
AUM Growth
+$569M
(+13%)
Cap. Flow
+$104M
Cap. Flow
% of AUM
2.08%
Top 10 Holdings %
Top 10 Hldgs %
38.84%
Holding
3,762
New
251
Increased
1,450
Reduced
1,277
Closed
224
Avg Time Held Equity + Options
4.7
years
Top 10 Avg Time Held Equity + Options
2.9
years
Top 20 Avg Time Held Equity + Options
3.8
years
Avg Time Held Equity only
4.7
years
Top 10 Avg Time Held Equity only
2.9
years
Top 20 Avg Time Held Equity only
3.8
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$18.4M |
| 2 |
iShares Core S&P Total US Stock Market ETF
ITOT
|
+$9.77M |
| 3 |
BlackRock US Equity Factor Rotation ETF
DYNF
|
+$5.48M |
| 4 |
Microsoft
MSFT
|
+$4.93M |
| 5 |
Vanguard S&P 500 ETF
VOO
|
+$4.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Corcept Therapeutics
CORT
|
+$7.34M |
| 2 |
Starbucks
SBUX
|
+$4.7M |
| 3 |
iShares California Muni Bond ETF
CMF
|
+$3.3M |
| 4 |
Invesco S&P 500 Equal Weight ETF
RSP
|
+$2.63M |
| 5 |
Vanguard Morningstar Small-Cap ETF
VB
|
+$1.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 46.71% |
| 2 | Technology | 17.21% |
| 3 | Healthcare | 9.68% |
| 4 | Financials | 7.2% |
| 5 | Communication Services | 5.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
926
Telefônica Brasil
VIV
$19.8B
| $240K | ﹤0.01% |
21,088
+6,222
| +42% | +$61.1K |
2016 Q4
34 quarters
|
|
927
Ryder
R
$9.11B
| $240K | ﹤0.01% |
1,511
-40
| -3% | -$5.88K |
2016 Q4
34 quarters
|
|
928
SBA Communications
SBAC
$19.7B
| $240K | ﹤0.01% |
1,022
+82
| +9% | +$18.8K |
2016 Q4
34 quarters
|
|
929
Ventas
VTR
$44B
| $240K | ﹤0.01% |
3,795
-70
| -2% | -$4.57K |
2016 Q4
34 quarters
|
|
930
Timken Company
TKR
$7.84B
| $239K | ﹤0.01% |
3,299
-317
| -9% | -$21.6K |
2019 Q3
23 quarters
|
|
931
iShares Russell Top 200 Growth ETF
IWY
$16.3B
| $239K | ﹤0.01% |
970
+39
| +4% | +$8.68K |
2024 Q2
4 quarters
|
|
932
The Marzetti Company
MZTI
$2.85B
| $238K | ﹤0.01% |
1,377
-351
| -20% | -$60.6K |
2016 Q4
34 quarters
|
|
933
State Street SPDR S&P 400 Mid Cap Growth ETF
MDYG
$2.78B
| $237K | ﹤0.01% |
2,731
-13
| -0.5% | -$1.06K |
2018 Q3
27 quarters
|
|
934
AtriCure
ATRC
$2.87B
| $237K | ﹤0.01% |
7,229
| – | – |
2019 Q3
23 quarters
|
|
935
Dentsply Sirona
XRAY
$1.73B
| $237K | ﹤0.01% |
14,910
+8,760
| +142% | +$131K |
2016 Q4
34 quarters
|
|
936
DELISTED
AvalonBay Communities
AVB
| $237K | ﹤0.01% |
1,163
+158
| +16% | +$32.3K |
2016 Q4
34 quarters
|
|
937
Oaktree Specialty Lending
OCSL
$1.03B
| $236K | ﹤0.01% |
17,250
| – | – |
2022 Q4
10 quarters
|
|
938
iShares 0-5 Year Investment Grade Corporate Bond ETF
SLQD
$2.43B
| $234K | ﹤0.01% |
4,635
+1,900
| +69% | +$95.4K |
2019 Q2
24 quarters
|
|
939
Solventum
SOLV
$14.6B
| $234K | ﹤0.01% |
3,080
-261
| -8% | -$18.5K |
2024 Q2
4 quarters
|
|
940
Canadian Imperial Bank of Commerce
CM
$102B
| $233K | ﹤0.01% |
3,288
+160
| +5% | +$10.3K |
2016 Q4
34 quarters
|
|
941
MGM Resorts International
MGM
$7.28B
| $232K | ﹤0.01% |
6,748
+482
| +8% | +$15.3K |
2016 Q4
34 quarters
|
|
942
Teledyne Technologies
TDY
$28.7B
| $232K | ﹤0.01% |
453
+76
| +20% | +$36.7K |
2016 Q4
34 quarters
|
|
943
Zoom
ZM
$27.6B
| $232K | ﹤0.01% |
2,970
+638
| +27% | +$49.3K |
2019 Q3
23 quarters
|
|
944
W.P. Carey
WPC
$14.8B
| $231K | ﹤0.01% |
3,705
-449
| -11% | -$27.6K |
2016 Q4
34 quarters
|
|
945
Conagra Brands
CAG
$6.83B
| $231K | ﹤0.01% |
11,289
+2,322
| +26% | +$54.4K |
2016 Q4
34 quarters
|
|
946
Schneider National
SNDR
$5.49B
| $231K | ﹤0.01% |
9,567
-1,127
| -11% | -$26.2K |
2019 Q3
23 quarters
|
|
947
CNX Resources
CNX
$5.31B
| $230K | ﹤0.01% |
6,836
+282
| +4% | +$8.88K |
2016 Q4
34 quarters
|
|
948
Canadian Natural Resources
CNQ
$110B
| $230K | ﹤0.01% |
7,318
-1,052
| -13% | -$31.9K |
2016 Q4
34 quarters
|
|
949
Invesco Ultra Short Duration ETF
GSY
$3.86B
| $230K | ﹤0.01% |
4,580
-720
| -14% | -$36.1K |
2018 Q1
29 quarters
|
|
950
Avery Dennison
AVY
$13.3B
| $229K | ﹤0.01% |
1,307
+197
| +18% | +$34.5K |
2016 Q4
34 quarters
|
|
Similar funds
Parallel Advisors's Q2 2025 Portfolio in Review
As of Q2 2025, Parallel Advisors held 3,762 positions worth $5B, up 13% from $4.43B the previous quarter. Its ten largest holdings account for 39% of the portfolio.
Parallel Advisors's Q2 2025 filing shows 251 new, 1,450 increased, 1,277 reduced and 224 closed positions. Its largest new stake was Vanguard 0-3 Month Treasury Bill ETF: 32,722 shares worth $2.47M. The largest sale was Corcept Therapeutics, an estimated $7.34M.
By sector, the portfolio is most concentrated in Miscellaneous at 47% of assets, down from 47% a quarter earlier, followed by Technology and Healthcare.
- Parallel Advisors's largest Q2 2025 buy was Vanguard 0-3 Month Treasury Bill ETF: 32,722 shares worth $2.47M.
- Parallel Advisors added most to iShares Core S&P 500 ETF in Q2 2025, an estimated $18.4M increase.
- Parallel Advisors's biggest Q2 2025 reduction was Corcept Therapeutics, cutting an estimated $7.34M.
- Parallel Advisors fully exited Discover Financial Services in Q2 2025, selling an estimated $1.22M.
- Parallel Advisors's ten largest holdings make up 39% of its $5B portfolio in Q2 2025.
- Parallel Advisors opened 251 new positions and closed 224 in Q2 2025.
- Parallel Advisors's portfolio value rose 13% quarter-over-quarter to $5B.
Based on Parallel Advisors's 13F filing for Q2 2025, filed 8 Jul 2025.